Literature DB >> 16265072

Mechanisms of disease: Carcinogenesis in Barrett's esophagus.

Navtej S Buttar1, Kenneth K Wang.   

Abstract

The pathogenesis of cancer in Barrett's esophagus is multifactorial. Gastroesophageal reflux seems to be important in the initiation of Barrett's esophagus, but its role in promoting carcinogenesis has yet to be established. Diet, lifestyle and carcinogens, especially the nitrates, may be important in the development of carcinogenesis, and require further investigation. Inhibition of reflux-stimulated inflammatory changes, for example by inhibiting cyclooxygenase, holds promise for decreasing cancer progression. Similarly, dietary and lifestyle modification used in the management of reflux may also help to prevent the development of esophageal cancer. The molecular changes that are associated with the development of cancer in Barrett's esophagus offer several potential areas of intervention to prevent and manage esophageal cancer. Limiting cell growth, increasing apoptosis of damaged cells, limiting cell invasion and angiogenesis factors could be useful to accomplish this goal. Having a greater understanding of the pathogenesis of this condition can only help to develop more management options in the future.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16265072     DOI: 10.1038/ncpgasthep0057

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN: 1743-4378


  17 in total

Review 1.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

2.  Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis.

Authors:  Sumera Rizvi; Cathrine J Demars; Andrea Comba; Vladimir G Gainullin; Zaheer Rizvi; Luciana L Almada; Kenneth Wang; Gwen Lomberk; Martin E Fernández-Zapico; Navtej S Buttar
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

3.  TGF-β is insufficient to induce adipocyte state loss without concurrent PPARγ downregulation.

Authors:  Brooks Taylor; Arnav Shah; Ewa Bielczyk-Maczyńska
Journal:  Sci Rep       Date:  2020-08-21       Impact factor: 4.379

4.  Globular adiponectin inhibits leptin-stimulated esophageal adenocarcinoma cell proliferation via adiponectin receptor 2-mediated suppression of UHRF1.

Authors:  Jun Wang; Yan Cheng; Xiaoran Yin; Jie Wu; Yumei Luo; Jing Wu; Jia Di; Dong Liu; Yahui Huang; Rong Zhang; Jun Zhang
Journal:  Mol Cell Biochem       Date:  2017-03-11       Impact factor: 3.396

5.  Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis.

Authors:  Navtej S Buttar; Cathrine J DeMars; Gwen Lomberk; Sumera Rizvi; Juliana Bonilla-Velez; Shalini Achra; Shahrooz Rashtak; Kenneth K Wang; Martin E Fernandez-Zapico; Raul Urrutia
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

6.  SOX2 as a novel marker to predict neoplastic progression in Barrett's esophagus.

Authors:  Sophie van Olphen; Katharina Biermann; Manon C W Spaander; Florine Kastelein; Ewout W Steyerberg; Hans A Stoop; Marco J Bruno; Leendert H J Looijenga
Journal:  Am J Gastroenterol       Date:  2015-09-01       Impact factor: 10.864

7.  Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.

Authors:  Chia-Jui Yen; Julie G Izzo; Dung-Fang Lee; Sushovan Guha; Yongkun Wei; Tsung-Teh Wu; Chun-Te Chen; Hsu-Ping Kuo; Jung-Mao Hsu; Hui-Lung Sun; Chao-Kai Chou; Navtej S Buttar; Kenneth K Wang; Peng Huang; Jaffer Ajani; Mien-Chie Hung
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

Review 8.  Chemoprevention in Barrett's esophagus.

Authors:  Sumera Ilyas; Cathrine J DeMars; Navtej S Buttar
Journal:  J Gastrointest Cancer       Date:  2007

9.  COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma.

Authors:  Shumei Song; Sushovan Guha; Kaifeng Liu; Navtej S Buttar; Robert S Bresalier
Journal:  Gut       Date:  2007-06-29       Impact factor: 23.059

10.  A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus.

Authors:  Gary W Falk; Navtej S Buttar; Nathan R Foster; Katie L Allen Ziegler; Catherine J Demars; Yvonne Romero; Norman E Marcon; Thomas Schnell; Douglas A Corley; Prateek Sharma; Marcia R Cruz-Correa; Chin Hur; David E Fleischer; Amitabh Chak; Kenneth R Devault; David S Weinberg; Gary Della'Zanna; Ellen Richmond; Thomas C Smyrk; Sumithra J Mandrekar; Paul J Limburg
Journal:  Gastroenterology       Date:  2012-07-11       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.